IKB kinase and methods of using same
US6268194A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Feb 25, 1997 |
| Grant date | Jul 31, 2001 |
| Priority date | — |
| Expiry date | Feb 25, 2017 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/9121
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides a substantially purified nucleic acid molecule encoding a serine protein kinase (I.kappa.B kinase) that phosphorylates a protein (I.kappa.B) that inhibits the activity of the NF-.kappa.B transcription factor, vectors comprising such a nucleic acid molecule and host cells containing such vectors. In addition, the invention provides nucleotide sequences that can bind to a nucleic acid molecule of the invention, such nucleotide sequences being useful as probes or as antisense molecules. The invention also provides a substantially purified I.kappa.B kinase, which is a polypeptide that can phosphorylate an I.kappa.B protein, and peptide portions of the I.kappa.B kinase. In addition, the invention provides anti-I.kappa.B kinase antibodies, which specifically bind to an I.kappa.B kinase, and I.kappa.B kinase-binding fragments of such antibodies. The invention further provides methods of substantially purifying an I.kappa.B kinase, methods of identifying an agent that can alter the association of an I.kappa.B kinase with a second protein, and methods of identifying proteins that can interact with an I.kappa.B kinase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.